Current Issue:
May 29, 2003
|
|
|
|
News, events, features |
|
Science/Research |
|
Latest
scientific findings |
|
|
|
The people behind the university |
|
|
|
Harvard and neighbor communities |
|
|
|
Scores, highlights, upcoming games |
|
|
| Newsmakers,
notes, students, police log |
|
|
|
Museums, concerts, theater |
|
|
|
Two-week listing of upcoming events |
 |
|
Gazette headlines delivered to your desktop |
|
|
|
May 29, 2003
|
New AIDS vaccine tested in U.S. and Africa
Raphael Dolin is part of a Medical School/School of Public Health research group conducting trials of a new AIDS vaccine in the U.S. and
Botswana. "This vaccine approach is very promising," says Dolin, Maxwell Finland Professor of Medicine and principal investigator of the Harvard HIV Vaccine Unit. "The vaccine is relatively easy to make and very stable. If it proves safe and gives us a good immune response, we can proceed to test its efficacy in large numbers of people, including those who are at high risk of HIV infection."
(Staff photo by Stephanie Mitchell) Full story
|
|
HARVARD GAZETTE ARCHIVES
New AIDS vaccine tested in U.S. and Africa
Trials in Boston, St. Louis, Botswana
|
